Last reviewed · How we verify
The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment
This study is examining the effects of growth hormone releasing hormone (GHRH) on mild cognitive impairment (MCI). GHRH will be given at a dose of 1mg/day for 10 weeks to subjects with MCI as well as healthy controls.
Details
| Lead sponsor | The University of Texas Medical Branch, Galveston |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 22 |
| Start date | Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Jan 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Mild Cognitive Impairment
Interventions
- Growth Hormone Releasing Hormone (GHRH)
- Placebo Growth Hormone Releasing Hormone
Countries
United States